Skip to main content
. 2020 Aug 5;70(2):265–273. doi: 10.1007/s00262-020-02684-8

Fig. 1.

Fig. 1

Forest plots showing the association of systemic therapy in metastatic renal cell carcinoma. a progression-free survival (PFS), b overall survival (OS), c adverse event (AE)